Citation Impact
Citing Papers
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Heparin-Protein Interactions
2002 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Prognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy
1995
Pulmonary hypertension in chronic obstructive pulmonary disease
2003
HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes
2006 StandoutNobel
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
CURRENT THOUGHTS REGARDING TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
1996
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Global incorporation of norleucine in place of methionine in cytochrome P450 BM‐3 heme domain increases peroxygenase activity
2003 StandoutNobel
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Tissue Destruction by Neutrophils
1989 Standout
Chronic obstructive pulmonary disease
1988
Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers
1988
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Pulmonary Hypertension in Chronic Lung Diseases
2013
Clinical classification of pulmonary hypertension
2004 Standout
Spontaneous Pneumothorax
2000 Standout
NO: COPD and beyond
1997
Pulmonary hypertension in chronic lung disease and hypoxia
2018
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
1999
Long-Term Oxygen Therapy
1995
Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
1987
Effects of Long-term Oxygen Therapy on Pulmonary Hemodynamics in COPD Patients
1998
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
Oxidation of methionyl residues in proteins: Tools, targets, and reversal
1995
Predictors for nocturnal hypoxaemia (mean SaO2 < 90%) in normoxic and mildly hypoxic patients with COPD
1995
Interpretative strategies for lung function tests
2005 Standout
Daytime Pulmonary Hypertension in Patients with Obstructive Sleep Apnea Syndrome
1988
Idiopathic pulmonary fibrosis
2017 Standout
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
1992
Chronic Obstructive Pulmonary Disease: Risk Factors, Pathophysiology and Pathogenesis
1989
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences
1996
CLINICAL CLASSIFICATION OF PULMONARY HYPERTERNSION
2001
The Role of Oxidative Stress in the Pathogenesis??of COPD
2005
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls
1999 Standout
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
2001 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Heparin-induced conformational change and activation of mucus proteinase inhibitor
1992
Practice Parameters for the Indications for Polysomnography and Related Procedures: An Update for 2005
2005 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
2007 Standout
Comparing the effect on protein stability of methionine oxidation versus mutagenesis: steps toward engineering oxidative resistance in proteins
2001
Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
1991
Inactivation of α 1 -Proteinase Inhibitor by Alveolar Inflammatory Cells from Smoking Patients with or without Emphysema
1993
The human side of hypoxia‐inducible factor
2008 StandoutNobel
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Pulmonary Vascular Involvement in COPD
2008
Pulmonary hypertension in COPD
2008
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
2005
Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research
2006
Gender-Related Differences in Severe, Early-Onset Chronic Obstructive Pulmonary Disease
2000
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
1999 Standout
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease
1999
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Pulmonary Hypertension Secondary to COPD
2012
Raised C-reactive protein levels in serum from smokers
1985
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Acute and subacute idiopathic interstitial pneumonias
2016
Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase.
1988
Hypoxic Pulmonary Vasoconstriction
2012
Immune and inflammatory function in cigarette smokers.
1987
Pulmonary Diseases and the Heart
2007
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Synthesis in E. coli of α1-antitrypsin variants of therapeutic potential for emphysema and thrombosis
1985 Nature
Physical Activity and Public Health in Older Adults
2007 Standout
Diagnosis and Treatment of Secondary (Non–Category 1) Pulmonary Hypertension
2008
Pathophysiology of Sleep Apnea
2010 Standout
Vascular and cardiac reactivity in pulmonary hypertension due to chronic obstructive lung disease: assessment with various oxygen concentrations
1992
(D) Routes of delivery: Case studies
1992
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia
1997
Works of A Pelletier being referenced
The Elastase Inhibitory Capacity and the α1-Proteinase Inhibitor and Bronchial Inhibitor Content of Bronchoalveolar Lavage Fluids from Healthy Subjects
1987
The Antielastase Screen of the Lower Respiratory Tract of Alpha 1 Proteinase Inhibitor-sufficient Patients with Emphysema or Pneumothorax
1990
Long-Term Oxygen Therapy Can Reverse the Progression of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
1985
Cryptogenic Organizing Pneumonia
2000
The functional activity of α1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers
1983